The EU's conditions for approving the deal do little to change hefty potential value to Microsoft's empire. But executing on the opportunity will take some work.
Fitbit has bought certain software assets from smartwatch maker Pebble.
Tesla's quality control efforts will increasingly be a focus as the company moves downmarket with its planned Model 3 sedan.
Chipotle's founder and CEO Steve Ells told investors at a conference on Tuesday that he was grading restaurants in the chain a 'C' partly because of slow service.
Starbucks will move forward with new stand-alone stores for its recently acquired bakery Princi.
Cisco has been working with countries around the world and discussing how the technology transition can change GDP growth.
Because of its well-established operations in the oil-rich Permian Basin, Occidental believes that it can increase production 5% to 8% over the long term.
Cascadian's tucatinib delays regrowth of breast cancer by a median of 7.8 months in newly updated study results presented this week.
Five private equity firms are reviewing Performance Sports Group's books to see if they want to make offers for the bankrupt sporting goods company ahead of a late-January deadline.
The country is finally on course to approve gaming resorts this year, which is boosting casino stocks in the United States, Macau and Malaysia.
The European Central Bank holds a key policy meeting on Thursday.
But a decline back below $140 would turn this picture neutral.
Toll Brothers shares surged on better-than-expected earnings, but the stock is likely to correct lower. Here's how to profit using stock options.
U.S. stocks fluctuated on Wednesday, after the Dow Jones Industrial Average reached another record high on Tuesday.
Apple supplier Foxconn said it's in preliminary talks to create a $7 billion investment program in the United States that would create 50,000 jobs.
Cascadian Therapeutics is enlarging its study of a breast cancer drug known as tucatinib.
The chances of the french drugs company muscling in on JNJ's talks with Actelion are slim based on Sanofi's cost of capital vs returns from a possible deal.
Two leading real estate technology companies have combined in a historic $300 million deal. Expert Jonathan Schultz, who co-founded Onyx Equities, discusses what it means for the industry next year.
The charts and indicators on APA remain bullish.
JPMorgan Chase, Credit Agricole and HSBC were fined some $521 million by the European Commission for rigging benchmark European interest rates, the Euribor.
The U.K. regulator takes exception to the sale of Epanutin to Flynn Pharma, which drove the price up by 2,600%.
This stock is still rising, despite market chatter on moving jobs overseas.
Starbucks will be adding flavors to its popular cold brew coffee.
Check out Jim and TheStreet editorial team’s latest analysis and commentary on what’s moving markets now.